Analysts Raise Target Prices on UNH Stock in September

Of the 23 analysts covering UNH stock, all of them have “buy” or “strong buy” recommendations for UnitedHealth Group.

Sarah Collins - Author

Sep. 6 2018, Updated 1:50 p.m. ET


Analysts’ views on UnitedHealth Group

As of September 5, according to a Reuters survey of 23 analysts covering UNH stock, all the analysts have “buy” or “strong buy” recommendations for UnitedHealth Group. Eleven of those analysts have a “strong buy” rating for the stock, and the remaining 12 have rated the stock a “buy.” None of the analysts gave it a “hold” or “sell” recommendation for UNH stock.

Article continues below advertisement
Article continues below advertisement

Target prices

According to the analysts, the consensus target price for UNH stock for the next 12 months is $284.50. That target price represents a return of ~6% for the next 12 months. It’s based on UNH’s closing price of $268.46.

Analysts’ average target prices for UNH peers Anthem (ANTM), Cigna (CI), and Aetna (AET) are $297.28, $223.06, and $203.27, respectively, implying 12.7%, 19.9%, and 1.2% returns over the next 12 months.

Recent ratings and target price updates

On September 5, Morgan Stanley raised its target price for UNH stock from $278 to $305. On September 4, Credit Suisse raised its target price from $270 to $304. In July, a number of investment research firms raised their recommendations and target prices after the company reported its Q2 2018 earnings results on July 17, although the stock fell that day.


Latest Anthem Inc News and Updates

    Opt-out of personalized ads

    © Copyright 2024 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.